IBDEI004 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358,14,2,1,0)
 ;;=3^1
 ;;^UTILITY(U,$J,358,15,0)
 ;;=NATIONAL DEMENTIA FY16-Q1^1^National Dementia Clinic November 2015^1^0^1^1^^133^80^2^1^^1^p^1^2.1
 ;;^UTILITY(U,$J,358,15,2,0)
 ;;=^358.02I^6^6
 ;;^UTILITY(U,$J,358,15,2,1,0)
 ;;=1^1
 ;;^UTILITY(U,$J,358,15,2,2,0)
 ;;=2^1
 ;;^UTILITY(U,$J,358,15,2,3,0)
 ;;=3^1
 ;;^UTILITY(U,$J,358,15,2,4,0)
 ;;=2^1
 ;;^UTILITY(U,$J,358,15,2,5,0)
 ;;=4^1
 ;;^UTILITY(U,$J,358,15,2,6,0)
 ;;=5^1
 ;;^UTILITY(U,$J,358,16,0)
 ;;=NATIONAL DERMATOLOGY FY16-Q1^0^National Derm Form-October 2015^1^0^^1^^133^80^9^1^^1^p^1^3
 ;;^UTILITY(U,$J,358,17,0)
 ;;=NATIONAL DIABETES FY16-Q1^2^NATIONAL DIABETES-November 2015^1^0^1^1^^133^80^3^1^^1^p^1^3
 ;;^UTILITY(U,$J,358,17,2,0)
 ;;=^358.02I^2^2
 ;;^UTILITY(U,$J,358,17,2,1,0)
 ;;=1^1
 ;;^UTILITY(U,$J,358,17,2,2,0)
 ;;=2^1
 ;;^UTILITY(U,$J,358,18,0)
 ;;=NATIONAL DIALYSIS FY16-Q1^2^National Dialysis November 2015^1^0^1^1^^133^80^6^1^^1^p^1^3
 ;;^UTILITY(U,$J,358,18,2,0)
 ;;=^358.02I^2^2
 ;;^UTILITY(U,$J,358,18,2,1,0)
 ;;=1^1
 ;;^UTILITY(U,$J,358,18,2,2,0)
 ;;=2^1
 ;;^UTILITY(U,$J,358,19,0)
 ;;=NATIONAL E-CONSULT FY16-Q1^1^National E-Consult Form October 2015^1^0^1^1^^133^80^16^1^^1^p^1^2.1
 ;;^UTILITY(U,$J,358,19,2,0)
 ;;=^358.02I^6^6
 ;;^UTILITY(U,$J,358,19,2,1,0)
 ;;=1^1
 ;;^UTILITY(U,$J,358,19,2,2,0)
 ;;=2^1
 ;;^UTILITY(U,$J,358,19,2,3,0)
 ;;=3^1
 ;;^UTILITY(U,$J,358,19,2,4,0)
 ;;=2^1
 ;;^UTILITY(U,$J,358,19,2,5,0)
 ;;=4^1
 ;;^UTILITY(U,$J,358,19,2,6,0)
 ;;=5^1
 ;;^UTILITY(U,$J,358,20,0)
 ;;=NATIONAL ECOE E&M FY16-Q1^2^NATIONAL EPILEPSY CENTER OF EXCELLENCE OFFICE VISITS October 2015^1^0^0^1^^133^80^2^1^^1^p^1^2.1
 ;;^UTILITY(U,$J,358,20,2,0)
 ;;=^358.02I^1^1
 ;;^UTILITY(U,$J,358,20,2,1,0)
 ;;=1^1
 ;;^UTILITY(U,$J,358,21,0)
 ;;=NATIONAL ECOE E-CON FY16-Q1^2^NATIONAL EPILEPSY CENTER OF EXCELLENCE E-CONSULTS October 2015^1^0^0^1^^133^80^2^1^^1^p^1^2.1
 ;;^UTILITY(U,$J,358,21,2,0)
 ;;=^358.02I^1^1
 ;;^UTILITY(U,$J,358,21,2,1,0)
 ;;=1^1
 ;;^UTILITY(U,$J,358,22,0)
 ;;=NATIONAL ECOE PROC FY16-Q1^2^NATIONAL EPILEPSY CENTER OF EXCELLENCE PROCEDURES October 2015^1^0^0^1^^133^80^2^1^^1^p^1^2.1
 ;;^UTILITY(U,$J,358,22,2,0)
 ;;=^358.02I^1^1
 ;;^UTILITY(U,$J,358,22,2,1,0)
 ;;=1^1
 ;;^UTILITY(U,$J,358,23,0)
 ;;=NATIONAL ECOE TELE FY16-Q1^2^NATIONAL EPILEPSY CENTER OF EXCELLENCE TELEPHONE October 2015^1^0^0^1^^133^80^2^1^^1^p^1^2.1
 ;;^UTILITY(U,$J,358,23,2,0)
 ;;=^358.02I^1^1
 ;;^UTILITY(U,$J,358,23,2,1,0)
 ;;=1^1
 ;;^UTILITY(U,$J,358,24,0)
 ;;=NATIONAL ED FY16-Q1^1^National Emergency Dept Form October 2015^1^0^1^1^^133^80^30^1^^1^p^1^2.1
 ;;^UTILITY(U,$J,358,24,2,0)
 ;;=^358.02I^6^6
 ;;^UTILITY(U,$J,358,24,2,1,0)
 ;;=1^1
 ;;^UTILITY(U,$J,358,24,2,2,0)
 ;;=2^1
 ;;^UTILITY(U,$J,358,24,2,3,0)
 ;;=3^1
 ;;^UTILITY(U,$J,358,24,2,4,0)
 ;;=2^1
 ;;^UTILITY(U,$J,358,24,2,5,0)
 ;;=4^1
 ;;^UTILITY(U,$J,358,24,2,6,0)
 ;;=5^1
 ;;^UTILITY(U,$J,358,25,0)
 ;;=NATIONAL EMP HEALTH FY16-Q1^1^National Employee Health November 2015^1^0^1^1^^133^80^5^1^^1^p^1^2.1
 ;;^UTILITY(U,$J,358,25,2,0)
 ;;=^358.02I^6^6
 ;;^UTILITY(U,$J,358,25,2,1,0)
 ;;=1^1
 ;;^UTILITY(U,$J,358,25,2,2,0)
 ;;=2^1
 ;;^UTILITY(U,$J,358,25,2,3,0)
 ;;=3^1
 ;;^UTILITY(U,$J,358,25,2,4,0)
 ;;=2^1
 ;;^UTILITY(U,$J,358,25,2,5,0)
 ;;=4^1
 ;;^UTILITY(U,$J,358,25,2,6,0)
 ;;=5^1
 ;;^UTILITY(U,$J,358,26,0)
 ;;=NATIONAL ENDOCRINOLOGY FY16-Q1^0^National Endocrinology November 2015^1^0^1^1^^133^80^2^1^^1^p^1^2.1
 ;;^UTILITY(U,$J,358,27,0)
 ;;=NATIONAL ENT FY16-Q1^2^NATIONAL ENT-REVIEWED/REVISED September 2015^1^0^1^1^^133^80^3^1^^1^p^1^2.1
 ;;^UTILITY(U,$J,358,27,2,0)
 ;;=^358.02I^2^2
 ;;^UTILITY(U,$J,358,27,2,1,0)
 ;;=1^1
